IRON
Price:
$50.35
Market Cap:
$1.50B
Disc Medicine, Inc., a clinical-stage biotechnology company, engages in discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases. It builds a portfolio of therapeutic candidates that address a spectrum of hematologic diseases by targeting fundamental biological pathways of red blood cell biology, primarily heme biosynthesis and iron homeostasis. The company is based in Watertown, Massachusetts.[Read more]
Industry
Biotechnology
IPO Date
2020-08-12
Stock Exchange
NASDAQ
Ticker
IRON
According to Disc Medicine, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -13.64. This represents a change of 1.35% compared to the average of -13.46 of the last 4 quarters.
The mean historical PE Ratio of Disc Medicine, Inc. over the last ten years is -7.51. The current -13.64 PE Ratio has changed 18.06% with respect to the historical average. Over the past ten years (40 quarters), IRON's PE Ratio was at its highest in in the December 2020 quarter at 13.56. The PE Ratio was at its lowest in in the September 2023 quarter at -20.22.
Average
-7.51
Median
-6.36
Minimum
-16.86
Maximum
-0.45
Discovering the peaks and valleys of Disc Medicine, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 3.66%
Maximum Annual PE Ratio = -0.45
Minimum Annual Increase = -80.26%
Minimum Annual PE Ratio = -16.86
Year | PE Ratio | Change |
---|---|---|
2023 | -16.86 | 3.66% |
2022 | -0.45 | -80.26% |
2021 | -2.27 | -78.26% |
The current PE Ratio of Disc Medicine, Inc. (IRON) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-6.53
5-year avg
-7.51
10-year avg
-7.51
Disc Medicine, Inc.’s PE Ratio is less than Anebulo Pharmaceuticals, Inc. (-4.99), less than Adagene Inc. (-2.86), less than Acrivon Therapeutics, Inc. Common Stock (-4.23), less than AnaptysBio, Inc. (-5.77), less than Mineralys Therapeutics, Inc. (-4.63), less than Olema Pharmaceuticals, Inc. (-6.07), less than Larimar Therapeutics, Inc. (-8.80), less than Fennec Pharmaceuticals Inc. (54.24), less than Orchestra BioMed Holdings, Inc. (-3.61), less than Biomea Fusion, Inc. (-1.83), greater than Structure Therapeutics Inc. (-18.15), greater than DICE Therapeutics, Inc. (-23.17), greater than Morphic Holding, Inc. (-15.88), less than Terns Pharmaceuticals, Inc. (-6.06), less than Day One Biopharmaceuticals, Inc. (-7.39), less than Acumen Pharmaceuticals, Inc. (-2.06), less than Amylyx Pharmaceuticals, Inc. (-0.97), greater than MoonLake Immunotherapeutics (-52.80), greater than Crinetics Pharmaceuticals, Inc. (-15.40), less than Centessa Pharmaceuticals plc (-9.93), less than Entrada Therapeutics, Inc. (4.84),
Company | PE Ratio | Market cap |
---|---|---|
-4.99 | $46.68M | |
-2.86 | $115.55M | |
-4.23 | $250.26M | |
-5.77 | $1.08B | |
-4.63 | $558.43M | |
-6.07 | $677.46M | |
-8.80 | $513.64M | |
54.24 | $144.76M | |
-3.61 | $212.20M | |
-1.83 | $256.37M | |
-18.15 | $2.11B | |
-23.17 | $2.27B | |
-15.88 | $2.86B | |
-6.06 | $549.60M | |
-7.39 | $1.25B | |
-2.06 | $133.38M | |
-0.97 | $161.36M | |
-52.80 | $2.89B | |
-15.40 | $4.03B | |
-9.93 | $1.62B | |
4.84 | $550.55M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Disc Medicine, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Disc Medicine, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Disc Medicine, Inc.'s PE Ratio?
How is the PE Ratio calculated for Disc Medicine, Inc. (IRON)?
What is the highest PE Ratio for Disc Medicine, Inc. (IRON)?
What is the 3-year average PE Ratio for Disc Medicine, Inc. (IRON)?
What is the 5-year average PE Ratio for Disc Medicine, Inc. (IRON)?
How does the current PE Ratio for Disc Medicine, Inc. (IRON) compare to its historical average?